JP2017538672A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017538672A5 JP2017538672A5 JP2017522532A JP2017522532A JP2017538672A5 JP 2017538672 A5 JP2017538672 A5 JP 2017538672A5 JP 2017522532 A JP2017522532 A JP 2017522532A JP 2017522532 A JP2017522532 A JP 2017522532A JP 2017538672 A5 JP2017538672 A5 JP 2017538672A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cmv
- amino acid
- acid sequence
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14189897 | 2014-10-22 | ||
| EP14189897.3 | 2014-10-22 | ||
| EP15184192.1 | 2015-09-08 | ||
| EP15184192 | 2015-09-08 | ||
| PCT/EP2015/074269 WO2016062720A1 (en) | 2014-10-22 | 2015-10-20 | Modified virus-like particles of cmv |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017538672A JP2017538672A (ja) | 2017-12-28 |
| JP2017538672A5 true JP2017538672A5 (https=) | 2018-11-22 |
| JP6942313B2 JP6942313B2 (ja) | 2021-09-29 |
Family
ID=54337283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017522532A Active JP6942313B2 (ja) | 2014-10-22 | 2015-10-20 | Ｃｍｖ由来改変ウイルス様粒子 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US10532107B2 (https=) |
| EP (1) | EP3209326A1 (https=) |
| JP (1) | JP6942313B2 (https=) |
| KR (2) | KR20250034187A (https=) |
| CN (2) | CN114685626B (https=) |
| AU (1) | AU2015335027B2 (https=) |
| CA (1) | CA2963709A1 (https=) |
| CL (1) | CL2017000987A1 (https=) |
| CO (1) | CO2017004119A2 (https=) |
| IL (1) | IL251532B (https=) |
| MA (1) | MA40824A (https=) |
| MX (1) | MX387985B (https=) |
| MY (1) | MY187462A (https=) |
| NZ (1) | NZ731205A (https=) |
| PE (1) | PE20171133A1 (https=) |
| PH (1) | PH12017500727A1 (https=) |
| RU (1) | RU2706970C2 (https=) |
| SG (2) | SG11201703083QA (https=) |
| TN (1) | TN2017000133A1 (https=) |
| WO (1) | WO2016062720A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA40824A (fr) * | 2014-10-22 | 2017-08-29 | Saiba Gmbh | Particules de cmv de type virus modifié |
| WO2017179025A1 (en) | 2016-04-15 | 2017-10-19 | Alk-Abelló A/S | Epitope polypeptides of ragweed pollen allergens |
| WO2017186808A1 (en) * | 2016-04-27 | 2017-11-02 | Allergy Therapeutics (Uk) Limited | Treatment of peanut allergy |
| BR112018071965A2 (pt) * | 2016-04-27 | 2019-03-06 | Benchmark Animal Health Ltd | tratamento da dermatite atópica canina |
| CA3054389A1 (en) * | 2017-03-07 | 2018-09-13 | Universitat Zurich | Treatment of pruritus in horses |
| MX2020006105A (es) * | 2017-12-11 | 2020-11-09 | Ubi Ip Holdings | Inmunógenos peptídicos de il-31 y formulaciones de estos para el tratamiento y/o la prevención de la dermatitis atópica. |
| AU2019236328B2 (en) | 2018-03-16 | 2025-10-09 | Zoetis Services Llc | Peptide vaccines against Interleukin-31 |
| EP3773712A1 (en) | 2018-04-10 | 2021-02-17 | AC Immune SA | Anti-abeta therapeutic vaccines |
| AU2019278596A1 (en) | 2018-05-28 | 2020-12-24 | Evax Ag | Treatment of urticaria |
| WO2020128037A1 (en) * | 2018-12-20 | 2020-06-25 | Saiba Gmbh | Virus-like particles of cmv modified by fusion |
| WO2020142522A2 (en) * | 2018-12-31 | 2020-07-09 | United Neuroscience | Peptide immunogens targeting calcitonin gene-related peptide (cgrp) and formulations thereof for prevention and treatment of migraine |
| WO2021083766A1 (en) | 2019-10-29 | 2021-05-06 | Evax Ag | Treatment of pruritus in horses |
| US20230038487A1 (en) * | 2019-11-25 | 2023-02-09 | The Regents Of The University Of California | Modified viral therapeutics and uses thereof |
| WO2021260131A1 (en) | 2020-06-25 | 2021-12-30 | Saiba AG | Virus-like particles of cmv modified by fusion |
| CA3201533A1 (en) * | 2020-11-11 | 2022-05-19 | European Molecular Biology Laboratory | Modified viral particles for gene therapy |
| CA3199586A1 (en) * | 2020-11-23 | 2022-05-27 | Samantha J. Busfield | Antigen-binding molecules and uses thereof |
| CN117534736A (zh) * | 2020-12-15 | 2024-02-09 | 深圳赫兹生命科学技术有限公司 | 一种用于生产vlp重组疫苗的cmv病毒样颗粒及其制备方法 |
| JP2025504361A (ja) | 2022-01-19 | 2025-02-12 | ウニベルズィテート ベルン | ウイルス様粒子と微結晶性チロシンとの組成物 |
| CN114437211B (zh) * | 2022-01-26 | 2024-03-12 | 南京麦西崴克生物科技有限公司 | 基于猫过敏原Fel d1的卵黄抗体的制备方法 |
| WO2023161528A1 (en) | 2022-02-28 | 2023-08-31 | Tridem Bioscience Gmbh & Co Kg | A CONJUGATE COMPRISING AT LEAST A ß-GLUCAN |
| JP2025507875A (ja) | 2022-02-28 | 2025-03-21 | トライデム バイオサイエンス ゲーエムベーハー ウント コンパニー カーゲー | 少なくともβ－グルカン若しくはマンナンからなるか、又はこれを含む結合体 |
| CN119789863A (zh) | 2022-08-30 | 2025-04-08 | 赛巴动物健康股份有限公司 | 经修饰的cmv病毒样颗粒 |
| CN118684781A (zh) * | 2023-03-21 | 2024-09-24 | 深圳赫兹生命科学技术有限公司 | GnRH-VLP重组去势疫苗及其制备方法 |
| GB202400747D0 (en) * | 2024-01-19 | 2024-03-06 | Univ Dundee | IL31-VLP and medical uses thereof |
| TW202536171A (zh) | 2024-03-04 | 2025-09-16 | 德商百靈佳殷格翰獸藥股份有限公司 | 用於治療ｎｇｆ相關病症之主動疫苗接種 |
| TW202544252A (zh) | 2024-03-06 | 2025-11-16 | 美商禮藍美國股份有限公司 | 經修飾的CMV類病毒粒子及貓IL-1β突變蛋白抗原之獸醫組成物 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6419931B1 (en) * | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
| EP1087784A1 (en) * | 1998-06-20 | 2001-04-04 | United Biomedical, Inc. | Synthetic somatostatin immunogen for growth promotion in farm animals |
| CA2407897A1 (en) * | 2000-05-05 | 2001-11-15 | Cytos Biotechnology Ag | Molecular antigen arrays and vaccines |
| AU7658101A (en) * | 2000-07-28 | 2002-02-13 | Cytos Biotechnology Ag | Compositions for inducing self-specific anti-ige antibodies and uses thereof |
| JP4533626B2 (ja) * | 2001-11-07 | 2010-09-01 | サイトス バイオテクノロジー アーゲー | アレルギー性好酸球性疾患を治療するための抗原アレイ |
| WO2003040164A2 (en) | 2001-11-07 | 2003-05-15 | Cytos Biotechnology Ag | Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases |
| WO2003103605A2 (en) | 2002-06-07 | 2003-12-18 | Large Scale Biology Corporation | Flexible vaccine assembly and vaccine delivery platform |
| EP2351770A1 (en) | 2002-07-17 | 2011-08-03 | Cytos Biotechnology AG | Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| GB0228715D0 (en) * | 2002-12-09 | 2003-01-15 | Glaxosmithkline Biolog Sa | Vaccine |
| EP1644034B1 (en) | 2003-07-10 | 2011-01-12 | Cytos Biotechnology AG | Composition for enhancing an immune response comprising packaged virus-like particles |
| WO2005091753A2 (en) | 2004-03-25 | 2005-10-06 | Large Scale Biology Corporation | Flexible vaccine assembly and vaccine delivery platform |
| US20090111702A1 (en) | 2004-04-06 | 2009-04-30 | Mount Sinai School Of Medicine Office Of Industrial Liason | Methods of determining allergen response using microarray immunoassay techniques |
| CA2580208A1 (en) * | 2004-09-21 | 2006-03-30 | Cytos Biotechnology Ag | Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide |
| US20060188500A1 (en) * | 2005-02-14 | 2006-08-24 | Leung Donald Y | Methods of predicting therpeutic response in atopic dermatitis to IL-31 antagonists |
| EP1868642B1 (en) * | 2005-03-18 | 2013-05-08 | Cytos Biotechnology AG | Cat allergen fusion proteins and uses thereof |
| EP1973608A1 (en) * | 2005-12-14 | 2008-10-01 | Cytos Biotechnology AG | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| WO2007113633A2 (en) | 2006-04-03 | 2007-10-11 | Pfizer Products Inc. | Immunogenic compositions comprising cat allergen fel dl |
| EP2140880B1 (en) | 2008-07-04 | 2012-11-14 | HAL Allergy Holding B.V. | Modification of allergens |
| AU2011258165B2 (en) * | 2010-05-26 | 2016-11-17 | Selecta Biosciences, Inc. | Dose selection of adjuvanted synthetic nanocarriers |
| US8790651B2 (en) * | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| HUP1100470A2 (en) * | 2011-08-30 | 2013-03-28 | Mezoegazdasagi Biotechnologiai Kutatokoezpont | Nanoparticle-based veterinary vaccine |
| CN102943087A (zh) * | 2012-11-26 | 2013-02-27 | 中国农业科学院上海兽医研究所 | 兔出血症病毒新型亚单位疫苗及其制备方法 |
| US10050902B2 (en) | 2013-10-28 | 2018-08-14 | Hitachi, Ltd. | Methods and apparatus for de-duplication and host based QoS in tiered storage system |
| MA40824A (fr) | 2014-10-22 | 2017-08-29 | Saiba Gmbh | Particules de cmv de type virus modifié |
| AU2016319075B2 (en) * | 2015-09-08 | 2022-09-22 | Universität Zürich | Compositions against cat allergy |
| JP6987744B2 (ja) * | 2015-09-08 | 2022-01-05 | ウニヴェルズィテート チューリッヒ | 虫刺され過敏症の治療 |
| WO2017186808A1 (en) | 2016-04-27 | 2017-11-02 | Allergy Therapeutics (Uk) Limited | Treatment of peanut allergy |
| BR112018071965A2 (pt) | 2016-04-27 | 2019-03-06 | Benchmark Animal Health Ltd | tratamento da dermatite atópica canina |
| WO2020128037A1 (en) | 2018-12-20 | 2020-06-25 | Saiba Gmbh | Virus-like particles of cmv modified by fusion |
-
2015
- 2015-10-19 MA MA040824A patent/MA40824A/fr unknown
- 2015-10-20 US US15/520,676 patent/US10532107B2/en active Active
- 2015-10-20 NZ NZ731205A patent/NZ731205A/en unknown
- 2015-10-20 WO PCT/EP2015/074269 patent/WO2016062720A1/en not_active Ceased
- 2015-10-20 SG SG11201703083QA patent/SG11201703083QA/en unknown
- 2015-10-20 MX MX2017005242A patent/MX387985B/es unknown
- 2015-10-20 MY MYPI2017701368A patent/MY187462A/en unknown
- 2015-10-20 PE PE2017000737A patent/PE20171133A1/es unknown
- 2015-10-20 KR KR1020257006196A patent/KR20250034187A/ko active Pending
- 2015-10-20 CN CN202210351341.8A patent/CN114685626B/zh active Active
- 2015-10-20 KR KR1020177013820A patent/KR102775741B1/ko active Active
- 2015-10-20 AU AU2015335027A patent/AU2015335027B2/en active Active
- 2015-10-20 RU RU2017111266A patent/RU2706970C2/ru active
- 2015-10-20 EP EP15781949.1A patent/EP3209326A1/en active Pending
- 2015-10-20 TN TN2017000133A patent/TN2017000133A1/en unknown
- 2015-10-20 CN CN201580064884.XA patent/CN108064276B/zh active Active
- 2015-10-20 JP JP2017522532A patent/JP6942313B2/ja active Active
- 2015-10-20 CA CA2963709A patent/CA2963709A1/en active Pending
- 2015-10-20 SG SG10201903538YA patent/SG10201903538YA/en unknown
-
2017
- 2017-04-03 IL IL251532A patent/IL251532B/en active IP Right Grant
- 2017-04-20 CL CL2017000987A patent/CL2017000987A1/es unknown
- 2017-04-20 PH PH12017500727A patent/PH12017500727A1/en unknown
- 2017-04-27 CO CONC2017/0004119A patent/CO2017004119A2/es unknown
-
2019
- 2019-11-26 US US16/696,161 patent/US11324836B2/en active Active
-
2022
- 2022-04-06 US US17/714,307 patent/US12605454B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017538672A5 (https=) | ||
| Balke et al. | Recent advances in the use of plant virus-like particles as vaccines | |
| Mahooti et al. | Immunomodulatory and prophylactic effects of Bifidobacterium bifidum probiotic strain on influenza infection in mice | |
| RU2017111266A (ru) | Модифицированные вирусоподобные частицы вируса мозаики огурца | |
| RU2486206C2 (ru) | Гипоаллергенный слитый белок, молекула нуклеиновой кислоты, кодирующая его, вектор экспрессии, клетка-хозяин, вакцинная композиция и его применение | |
| Deng et al. | Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge | |
| JP2014530010A5 (https=) | ||
| JP2006504653A5 (https=) | ||
| JP2015501840A5 (https=) | ||
| Shim et al. | Sublingual delivery of vaccines for the induction of mucosal immunity | |
| JP2011250797A5 (https=) | ||
| JP2012501959A5 (https=) | ||
| EA202090738A1 (ru) | Способ безопасного индуцирования иммунитета против rsv | |
| JP2019506175A5 (https=) | ||
| JP2024504566A (ja) | 核酸ワクチン | |
| JP2016511747A5 (https=) | ||
| TW202202169A (zh) | 預防嚴重急性呼吸症候群冠狀病毒第二型（ｓａｒｓ－ｃｏｖ－２）感染的生物可降解奈米複合物疫苗及方法 | |
| Bai et al. | Hollow mesoporous silica nanoparticles as delivery vehicle of foot‐and‐mouth disease virus‐like particles induce persistent immune responses in guinea pigs | |
| JP2010506926A5 (https=) | ||
| JP2020534874A (ja) | Ｃｄ４ヘルパーｔ細胞エピトープの融合ペプチドおよびそのワクチン | |
| Pan et al. | A double-blind, randomized controlled trial to evaluate the safety and immunogenicity of an intranasally administered trivalent inactivated influenza vaccine with the adjuvant LTh (αK): A phase II study | |
| Nagpal et al. | Current clinical status of new COVID-19 vaccines and immunotherapy | |
| Mansoor et al. | Intranasal delivery of nanoparticles encapsulating BPI3V proteins induces an early humoral immune response in mice | |
| Nie et al. | Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice | |
| Ramirez et al. | Co‐delivery of multiple toll‐like receptor agonists and avian influenza hemagglutinin on protein nanoparticles enhances vaccine immunogenicity and efficacy |